Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATA-1: Personality and Analgesics in Cardiac Surgery
NCT02756598Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2015
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, single-blind trial of sufentanil and propofol in cardiac surgery, sponsored by Aarhus University Hospital. Primary endpoints: Time to reach anaesthetic depth goal by bi-spectral index (BIS) at 30 months and Ventilation time at 24 hours. Started Jan 2015; status: completed.
02
Drugs
sufentanilpropofol
03
Conditions
cardiac surgery
Beyond the preview
Go deeper on NCT02756598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02756598.